Group One Trading
DNLI icon

Group One Trading’s Denali Therapeutics DNLI Stock Holding History

Group One Trading’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.6K Buy
805
+29
+4% +$679 ﹤0.01% 6008
2026
Q2 		$20K Buy
+776
New +$15.9K ﹤0.01% 6025
2024
Q4 		– Sell
-1,691
Closed -$43.3K – 7414
2024
Q3 		$49.3K Buy
+1,691
New +$41.9K ﹤0.01% 4660
2024
Q2 		– Sell
-8,455
Closed -$162K – 6878
2024
Q1 		$173K Buy
+8,455
New +$159K ﹤0.01% 3688
2023
Q2 		– Sell
-49,760
Closed -$1.4M – 7752
2023
Q1 		$1.15M Buy
+49,760
New +$1.37M ﹤0.01% 2019
2022
Q3 		– Sell
-3,522
Closed -$115K – 7661
2022
Q2 		$104K Sell
3,522
-3,437
-49% -$90K ﹤0.01% 4948
2022
Q1 		$224K Sell
6,959
-7,386
-51% -$254K ﹤0.01% 4683
2021
Q4 		$640K Buy
+14,345
New +$680K ﹤0.01% 3842
2021
Q3 		– Sell
-1,193
Closed -$67.2K – 8284
2021
Q2 		$94K Buy
+1,193
New +$73.8K ﹤0.01% 6025
2020
Q2 		– Sell
-5,756
Closed -$135K – 5855
2020
Q1 		$101K Buy
+5,756
New +$120K ﹤0.01% 3287
2019
Q4 		– Sell
-2,200
Closed -$36.6K – 5197
2019
Q3 		$34K Buy
+2,200
New +$42K ﹤0.01% 4159
2019
Q1 		– Sell
-100
Closed -$2.09K – 4918
2018
Q4 		$2K Buy
+100
New +$1.81K ﹤0.01% 4649

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Group One Trading's DNLI Position: Q3 2026 in Review

Group One Trading increased its Denali Therapeutics (DNLI) stake by 3.7% in Q3 2026, buying an estimated $679 and bringing the position to 805 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6008.

Group One Trading first reported a position in DNLI in Q4 2018 and has held it in 12 quarters since. The position peaked at $1.15M in Q1 2023. 140 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.

  • Group One Trading held 805 shares of Denali Therapeutics worth $16.6K as of Q3 2026.
  • Group One Trading bought 29 Denali Therapeutics shares in Q3 2026, an estimated $679.
  • Denali Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6008 holding.
  • Group One Trading first reported a position in Denali Therapeutics in Q4 2018 and has held it in 12 quarters since.
  • Group One Trading's Denali Therapeutics position peaked at $1.15M in Q1 2023.
  • 140 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.